Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

74.95
-1.7100-2.23%
Post-market: 75.000.0500+0.07%19:30 EDT
Volume:360.83K
Turnover:27.22M
Market Cap:3.85B
PE:23.06
High:78.48
Open:77.76
Low:74.74
Close:76.66
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:1.37
T/O Rate:1.30%
Dividend:2.58
Dividend Rate:3.44%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:6.54
PE(LYR):25.24

Loading ...

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

GlobeNewswire
·
Jun 01

Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month

GlobeNewswire
·
Jun 01

Cohen & Steers RNP fund pays $0.136 per share May distribution

Reuters
·
May 30

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

GlobeNewswire
·
May 29

Cohen & Steers launches three SICAV real asset funds in South Africa

Reuters
·
May 28

Cohen & Steers Infrastructure Fund sets May distribution at $0.165 per share

Reuters
·
May 28

Press Release: Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)

Dow Jones
·
May 28

Supernus Pharmaceuticals to Participate in June Investor Conferences

GlobeNewswire
·
May 28

Cohen & Steers President, CIO Jon Cheigh disposes of common shares worth $753,375

Reuters
·
May 28

TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial

GlobeNewswire
·
May 27

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

GlobeNewswire
·
May 27

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
May 27

Press Release: Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC

Dow Jones
·
May 27

Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference

GlobeNewswire
·
May 27

TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting

GlobeNewswire
·
May 26

Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases

GlobeNewswire
·
May 26

Press Release: Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Dow Jones
·
May 26

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting

GlobeNewswire
·
May 26

A Look At Cohen & Steers (CNS) Valuation After New J.P. Morgan Distribution Partnership

Simply Wall St.
·
May 25

Cohen & Steers Appoints Amit Muni as New CFO

TIPRANKS
·
May 22